Qinqin Meng

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Case Report: Successful treatment of pityriasis rubra pilaris with deucravacitinib.

Case Report: Successful treatment of pityriasis rubra pilaris with deucravacitinib.

Journal: Frontiers in immunology

Published: November 25, 2025

Microneedles meet photomedicine: emerging strategies for diagnosis and therapy of skin diseases.

Microneedles meet photomedicine: emerging strategies for diagnosis and therapy of skin diseases.

Journal: Nanoscale advances

Published: November 03, 2025

Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases.

Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases.

Journal: Frontiers in medicine

Published: June 23, 2025

Case Report: Guselkumab treatment for sintilimab-exacerbated psoriasis in a cancer patient.

Case Report: Guselkumab treatment for sintilimab-exacerbated psoriasis in a cancer patient.

Journal: Frontiers in immunology

Published: February 09, 2025

SIRT3 alleviates imiquimod-induced psoriatic dermatitis through deacetylation of XBP1s and modulation of TLR7/8 inducing IL-23 production in macrophages.

SIRT3 alleviates imiquimod-induced psoriatic dermatitis through deacetylation of XBP1s and modulation of TLR7/8 inducing IL-23 production in macrophages.

Journal: Frontiers in immunology

Published: December 21, 2022

Sex-differential downregulation of methotrexate on plasma viscosity and whole blood viscosity in psoriasis.

Sex-differential downregulation of methotrexate on plasma viscosity and whole blood viscosity in psoriasis.

Journal: Clinical hemorheology and microcirculation

Published: April 25, 2022

Identification of Chemokines-Related miRNAs as Potential Biomarkers in Psoriasis Based on Integrated Bioinformatics Analysis.

Identification of Chemokines-Related miRNAs as Potential Biomarkers in Psoriasis Based on Integrated Bioinformatics Analysis.

Journal: Combinatorial chemistry & high throughput screening

Published: February 24, 2022

MicroRNA-148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels.

MicroRNA-148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels.

Journal: BioMed research international

Published: April 18, 2020

A case of early localized scleroderma that was manifested as a port-wine stain.

A case of early localized scleroderma that was manifested as a port-wine stain.

Journal: Postepy dermatologii i alergologii

Published: October 09, 2019

[Corrigendum] Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1‑5 and increased expression of SIRT 6 and 7.

[Corrigendum] Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1‑5 and increased expression of SIRT 6 and 7.

Journal: International journal of molecular medicine

Published: August 10, 2018

Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7.

Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7.

Journal: International journal of molecular medicine

Published: August 10, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026